相关实验视频

Updated: Jun 13, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.1K

关于肺动脉高血压的最新评论:唐氏综合征和非唐氏综合征人群之间的差异

Guillermo Cueto-Robledo1, Ernesto Roldan-Valadez2, Melissa Garcia-Lezama3

  • 1Hospital General de México, Cardiorespiratory Emergencies, 06720, Mexico City, Mexico; Hospital General de México, Pulmonary Circulation Clinic, 06720, Mexico City, Mexico; National Autonomous University of Mexico, Faculty of Medicine, 04510, Mexico City, Mexico.

Current problems in cardiology
|September 11, 2024
PubMed
概括

患有唐氏综合征 (DS) 和肺动脉高血压 (PAH) 的患者比没有DS的患者更早出现并有更好的生存率. 量身定制的管理对于这个独特的群体至关重要.

关键词:
遗传性心脏病是一种先天性心脏病.唐氏综合征是什么意思 唐氏综合征心声回声扫描 (Echocardiography) 是一种心声回声扫描.血液动力学概况 血液动力学概况个性化医疗是个性化的医疗.肺动脉高血压是肺动脉高血压.右心脏导管装置的使用.对生存分析的分析.

更多相关视频

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

7.1K
In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

357

相关概念视频

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
158
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
136
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
141